CJC-1295

CJC-1295 is a synthetic peptide analog of growth hormone–releasing hormone (GHRH), developed to support sustained stimulation of growth hormone signaling pathways in research settings. By binding to GHRH receptors in the pituitary, CJC-1295 has been widely studied for its ability to increase the amplitude and duration of endogenous growth hormone release without significantly disrupting natural pulsatility.

In preclinical and laboratory research, CJC-1295 has been investigated for its role in metabolic regulation, protein synthesis, cellular repair mechanisms, and tissue regeneration. Its extended half-life, achieved through structural modification, allows for prolonged receptor interaction, making it a peptide of interest in studies focused on aging, muscle physiology, and recovery processes.

Pure Edge Peptides’ CJC-1295 is manufactured to stringent purity standards and supplied exclusively for research use only. Each vial undergoes quality control testing to ensure consistency, stability, and reliability for experimental applications.

Not for human or veterinary use.
Intended for laboratory research purposes only.